Sign up to save your podcasts
Or
Share Episode 15 - Ervebo, Enhertu, & Ubrelvy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 15 - Ervebo, Enhertu, & Ubrelvy
Our first episode of 2020! In Episode 15 we discuss multiple approvals by the FDA including Ervebo for treatment of Ebola Virus Disease, Ubrelvy for treatment of migraines in adults, Dayvigo for insomnia (clever name... get it?), and Caplyta for treatment of schizophrenia in adults. We also discuss added indication for Lynparza, and a new treatment called Enhertu for HER2 positive breast cancer. Happy New Year!
View all episodes
By Ian Parnigoni PharmD.Our first episode of 2020! In Episode 15 we discuss multiple approvals by the FDA including Ervebo for treatment of Ebola Virus Disease, Ubrelvy for treatment of migraines in adults, Dayvigo for insomnia (clever name... get it?), and Caplyta for treatment of schizophrenia in adults. We also discuss added indication for Lynparza, and a new treatment called Enhertu for HER2 positive breast cancer. Happy New Year!